BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mahady SE, Adams LA. Burden of non-alcoholic fatty liver disease in Australia: Burden of fatty liver in Australia. Journal of Gastroenterology and Hepatology 2018;33:1-11. [DOI: 10.1111/jgh.14270] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Nguyen XK, Zhang J, Chin KL, Bloom S, Nicoll AJ. Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver? Nutrients 2022;14:3875. [PMID: 36145251 DOI: 10.3390/nu14183875] [Reference Citation Analysis]
2 Ampuero J. General Overview About the Current Management of Nonalcoholic Fatty Liver Disease. Clin Drug Investig 2022. [PMID: 35467297 DOI: 10.1007/s40261-022-01142-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Welman CJ, Saunders J, Zelesco M, Abbott S, Boardman G, Ayonrinde OT. Hepatic steatosis: Ultrasound assessment using attenuation imaging (ATI) with liver biopsy correlation. J Med Imaging Radiat Oncol 2022. [PMID: 35466506 DOI: 10.1111/1754-9485.13412] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ramachandran P, Xu G, Huang HH, Rice R, Zhou B, Lindpaintner K, Serie D. Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. J Proteome Res 2022. [PMID: 35286803 DOI: 10.1021/acs.jproteome.1c00965] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mahajan VK, Chauhan NS, Rana BS, Mehta KS, Hooda S, Chauhan PS, Kukreja A. The Association Between Chronic Plaque Psoriasis and Nonalcoholic Fatty Liver Disease in Indian Patients: Results of a Pilot Study. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.11.016] [Reference Citation Analysis]
6 Majumdar A, Verbeek J, Tsochatzis EA. Non-alcoholic fatty liver disease: Current therapeutic options. Curr Opin Pharmacol 2021;61:98-105. [PMID: 34688168 DOI: 10.1016/j.coph.2021.09.007] [Reference Citation Analysis]
7 Kemp W, Clayton-Chubb D, Majeed A, Glenister KM, Magliano DJ, Lubel J, Bourke L, Simmons D, Roberts SK. Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study. J Gastroenterol Hepatol 2021. [PMID: 34693553 DOI: 10.1111/jgh.15723] [Reference Citation Analysis]
8 Sewter R, Heaney S, Patterson A. Coffee Consumption and the Progression of NAFLD: A Systematic Review. Nutrients 2021;13:2381. [PMID: 34371891 DOI: 10.3390/nu13072381] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Bishay RH, Meyerowitz-Katz G, Hng TM, Colaco CMG, Khanna S, Klein R, Sanjeev D, McLean M, Ahlenstiel G, Maberly GF. A retrospective case-control cohort analysis of comorbidity and health expenditure in hospitalized adults diagnosed with obesity utilizing ICD-10 diagnostic coding. Clin Obes 2021;:e12469. [PMID: 34053198 DOI: 10.1111/cob.12469] [Reference Citation Analysis]
10 Gracen L, Powell EE. Non-alcoholic fatty liver disease: raising awareness of a looming public health problem. Med J Aust 2021;215:75-6. [PMID: 34046909 DOI: 10.5694/mja2.51109] [Reference Citation Analysis]
11 Roberts SK, Majeed A, Glenister K, Magliano D, Lubel JS, Bourke L, Simmons D, Kemp WW. Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study. Med J Aust 2021;215:77-82. [PMID: 34028830 DOI: 10.5694/mja2.51096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Huang TD, Behary J, Zekry A. Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Intern Med J 2020;50:1038-47. [PMID: 31760676 DOI: 10.1111/imj.14709] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 27.0] [Reference Citation Analysis]
13 Gao Y, Zhang J, Xiao X, Ren Y, Yan X, Yue J, Wang T, Wu Z, Lv Y, Wu R. The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats. Front Cell Infect Microbiol 2021;11:640448. [PMID: 33869077 DOI: 10.3389/fcimb.2021.640448] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Hayward KL, Johnson AL, Horsfall LU, Moser C, Valery PC, Powell EE. Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM. BMJ Open Gastroenterol 2021;8:e000572. [PMID: 33568418 DOI: 10.1136/bmjgast-2020-000572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Majumdar A, Tsochatzis EA. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease. Metabolism 2020;111:154291. [DOI: 10.1016/j.metabol.2020.154291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
16 Ibacahe C, Correa-Burrows P, Burrows R, Barrera G, Kim E, Hirsch S, Jofré B, Blanco E, Gahagan S, Bunout D. Accuracy of a Semi-Quantitative Ultrasound Method to Determine Liver Fat Infiltration in Early Adulthood. Diagnostics (Basel) 2020;10:E431. [PMID: 32630407 DOI: 10.3390/diagnostics10060431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Cen C, Wang W, Yu S, Tang X, Liu J, Liu Y, Zhou L, Yu J, Zheng S. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease. Hepatol Int 2020;14:808-16. [PMID: 32572817 DOI: 10.1007/s12072-020-10065-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
18 Brain D, O'Beirne J, Hickman IJ, Powell EE, Valery PC, Kularatna S, Tulleners R, Farrington A, Horsfall L, Barnett A. Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD). BMC Health Serv Res 2020;20:335. [PMID: 32316984 DOI: 10.1186/s12913-020-05233-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 McSweeney L, Breckons M, Fattakhova G, Oluboyede Y, Vale L, Ternent L, Balp MM, Doward L, Brass CA, Beyer F, Sanyal A, Anstee QM. Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis. JHEP Rep 2020;2:100099. [PMID: 32435754 DOI: 10.1016/j.jhepr.2020.100099] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
20 Nguyen TH, Wardell R, Chitturi S, Teoh N, Farrell G. When the liver gets stiff, the tough get moving. J Gastroenterol Hepatol 2020;35:953-9. [PMID: 31867782 DOI: 10.1111/jgh.14963] [Reference Citation Analysis]
21 Magdaleno-Tapial J, Valenzuela-Oñate C, Ortiz-Salvador JM, Martínez-Doménech Á, García-Legaz-Martínez M, Alonso-Carpio M, Tamarit-García JJ, Diago-Madrid M, Sánchez-Carazo JL, Pérez-Ferriols A. Prevalence of non-alcoholic fatty liver and liver fibrosis in patients with moderate-severe psoriasis: A cross-sectional cohort study. Australas J Dermatol 2020;61:105-9. [PMID: 31731325 DOI: 10.1111/ajd.13175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
22 Teeratorn N, Piyachaturawat P, Thanapirom K, Chaiteerakij R, Sonsiri K, Komolmit P, Tangkijvanich P, Rerknimitr R, Adams L, Treeprasertsuk S. Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography.JGH Open. 2020;4:245-250. [PMID: 32280772 DOI: 10.1002/jgh3.12252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
23 Farrell GC, Wardell R, Teoh N, Chitturi S. Non-alcoholic fatty liver disease. Intern Med J 2019;49:681-3. [PMID: 31083812 DOI: 10.1111/imj.14283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, Qiu Y, Burns L, Afendy A, Nader F. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol. 2019;71:793-801. [PMID: 31279902 DOI: 10.1016/j.jhep.2019.06.021] [Cited by in Crossref: 295] [Cited by in F6Publishing: 289] [Article Influence: 98.3] [Reference Citation Analysis]
25 Gnocchi D, Custodero C, Sabbà C, Mazzocca A. Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology. J Mol Med (Berl) 2019;97:741-59. [PMID: 30953079 DOI: 10.1007/s00109-019-01780-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
26 Kutaiba N, Richmond D, Morey M, Brennan D, Rotella JA, Ardalan Z, Goodwin M. Incidental hepatic steatosis on unenhanced computed tomography performed for suspected renal colic: Gaps in reporting and documentation. J Med Imaging Radiat Oncol 2019;63:431-8. [PMID: 30874372 DOI: 10.1111/1754-9485.12873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]